Ed Mena

Ed.2

LifePharms LLC

2023

Technologies

Therapeutic

Indication

Drug Discovery

Infectious Disease

Women’s health

Executive Summary

View/Download

Additional Information

Minority-Led

Woman-Led

LifePharms LLC. is developing a novel antifungal compound. This compound is active both in vitro and in vivo against drug-resistant fungal infections.

Newsletter Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Corporate Supporters

Program of

Initiated by